Psychotic Disorders - Portugal

  • Portugal
  • Revenue in the Psychotic Disorders market is projected to reach US$69.74m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.36%, resulting in a market volume of US$70.99m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.55k are generated in 2024.

Key regions: Japan, Australia, Europe, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Psychotic Disorders market in Portugal is experiencing significant growth and development.

Customer preferences:
Customers in Portugal are increasingly seeking effective treatments for psychotic disorders, such as schizophrenia and bipolar disorder. They are looking for medications that can effectively manage symptoms and improve their quality of life. Additionally, there is a growing demand for non-pharmacological interventions, such as therapy and counseling, as customers recognize the importance of holistic approaches to mental health.

Trends in the market:
One trend in the Psychotic Disorders market in Portugal is the increasing use of atypical antipsychotic medications. These medications have gained popularity due to their efficacy in managing symptoms and their reduced side effects compared to older generation antipsychotics. Customers are more willing to try these newer medications, leading to a higher demand in the market.Another trend is the integration of technology in the treatment of psychotic disorders. Digital health solutions, such as mobile applications and online therapy platforms, are becoming more prevalent in Portugal. These tools provide customers with convenient access to mental health support and resources, and can complement traditional treatment methods.

Local special circumstances:
Portugal has made significant investments in its mental healthcare system in recent years. This has resulted in improved access to treatment for individuals with psychotic disorders. The government has implemented initiatives to reduce stigma surrounding mental health, which has encouraged more people to seek help and contribute to the growth of the market.

Underlying macroeconomic factors:
The growing Psychotic Disorders market in Portugal can also be attributed to favorable macroeconomic factors. The country has experienced economic growth and stability, which has increased healthcare spending. This has allowed for the expansion of mental health services and the availability of a wider range of treatment options.In conclusion, the Psychotic Disorders market in Portugal is developing due to customer preferences for effective treatments, the use of atypical antipsychotic medications, the integration of technology in mental healthcare, local initiatives to reduce stigma, and favorable macroeconomic factors. The market is expected to continue growing as more individuals seek help for their psychotic disorders and as the healthcare system continues to invest in mental health services.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)